Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Demyelinating Diseases: Myeloperoxidase as an Imaging Biomarker and Therapeutic Target.
The role of tumour necrosis factor α in the pathogenesis of multiple sclerosis, and pentoxifylline as a possible pharmacotherapeutic intervention.
Natalizumab use in pediatric patients with relapsing-remitting multiple sclerosis.
Targeting S1P receptors in experimental autoimmune encephalomyelitis in mice improves early deficits in locomotor activity and increases ultrasonic vocalisations.
Pain Research Forum: application of scientific social media frameworks in neuroscience.
Characterizing contrast-enhancing and re-enhancing lesions in multiple sclerosis.
Efficacy and safety of Alemtuzumab in treatment-naive patients with relapsing-remitting multiple sclerosis: Four-year follow-up of the Care-MS I study.
Using a highly abbreviated California Verbal Learning Test-II to detect verbal memory deficits.
▼Dimethyl fumarate for relapsing-remitting multiple sclerosis.
Conditional DC depletion does not affect priming of encephalitogenic Th cells in EAE.
Relationships Between Retinal Axonal and Neuronal Measures and Global Central Nervous System Pathology in Multiple Sclerosis.
Optical coherence tomography in multiple sclerosis.
Diagnostic Ability of a Linear Discriminant Function for Spectral-Domain Optical Coherence Tomography in Patients with Multiple Sclerosis.
Endocannabinoids and neurodegenerative diseases.
Kappa free light chains: diagnostic and prognostic relevance in MS and CIS.
The Ambivalent Role of Apoptosis in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
CCSVI and MS: a statement from the European Society of neurosonology and cerebral hemodynamics.
The anti-IL-17A antibody secukinumab does not attenuate ozone-induced airway neutrophilia in healthy volunteers.
Modest familial risks for multiple sclerosis: a registry-based study of the population of Sweden.
Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis.
Reduced axonal motor protein expression in non-lesional grey matter in multiple sclerosis.
[Cognitive performance and quality of life in multiple sclerosis in Gipuzkoa].
FTY720 (Fingolimod) Attenuates Beta-amyloid Peptide (Aβ(42))-Induced Impairment of Spatial Learning and Memory in Rats.
Tumefactive MS lesions under fingolimod: A case report and literature review.
Epitope-specific immune tolerization ameliorates experimental autoimmune encephalomyelitis.

Pages